Skerjanec Simona
SEC insider (Form 3/4/5 filer). CIK 0002022163. Director at IMMUNIC, INC. (IMUX) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 5, 2026. Located in NEW YORK, NY.
Companies Skerjanec Simona has filed insider reports for
- IMMUNIC, INC. (IMUX): Director
- Atrium Therapeutics, Inc. (RNA): Director
- Avidity Biosciences, Inc. (RNAM): Director
Skerjanec Simona
CIK: 0002022163
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (83.3%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 5, 2026IMUX
IMMUNIC, INC.
AwardDirectStock Option
25.4K shares- - Jun 29, 2026IMUX
IMMUNIC, INC.
AwardDirectStock Option
25.4K shares- - Feb 27, 2026RNA
Atrium Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
DispositionDirect6.7K shares- - Jun 10, 2025RNA
Avidity Biosciences, Inc.
AwardDirect6.7K shares- - Jun 5, 2025IMUX
IMMUNIC, INC.
AwardDirectStock Option
150K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 5, 2026 |  IMUX IMMUNIC, INC. | Award Stock Option | 25,370 | - | - | Direct |
| Jun 29, 2026 | IMUX IMMUNIC, INC. | Award Stock Option | 25,370 | - | - | Direct |
| Feb 27, 2026 |  RNA Atrium Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition | 6,692 | - | $0 | Direct |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | Award | 6,692 | - | - | Direct |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | Award Stock Option | 150,000 | - | - | Direct |
1-6 of 6 transactions